Available worldwide via Amazon (Kindle Edition)
US: $5.99
Other regions: Local Amazon pricing
Available here:
https://www.amazon.nl/dp/B0GMXLX56T
For decades, digital networks have functioned as reactive infrastructures. They transmitted signals, responded to requests and waited for human input. Agency was clear: users acted, systems followed. Efficiency was measured in speed, bandwidth and latency.
The MedTech landscape in 2026 is defined not just by innovation, but by how technology earns trust. As AI, robotics and data-driven care accelerate, the real differentiator is no longer what technology can do — but how human it feels. The Big Five—Philips, GE HealthCare, Medtronic, J&J MedTech and Siemens Healthineers—each navigate this tension differently.
For decades, the logic of telecommunications was almost uncontested. Faster was better. More bandwidth meant progress. Shannon’s Law framed intelligence as an engineering problem: how efficiently can information be transmitted from point A to point B?
Healthcare is becoming increasingly electronic. From wearable sensors and smart patches to remote diagnostics and continuous monitoring, digital technologies now sit directly on the human body — sometimes even inside it. These innovations promise earlier detection, better outcomes and more personalised care. Yet beneath this progress lies a growing contradiction.
In the world of medical technology, five giants dominate the landscape: Philips, Siemens Healthineers, GE HealthCare, Medtronic and Johnson & Johnson MedTech. They shape hospitals, diagnostic labs and operating rooms worldwide. But their influence goes far beyond machines and software: their story is one of technological innovation intertwined with human care, navigating governance challenges, mergers and ethically complex healthcare decisions.
Europe stands at a crossroads. AI, digital infrastructure, chip sovereignty and the shifting alliances of geopolitics are no longer distant considerations—they shape economies, influence global power and redefine opportunity. Yet political discourse often struggles to match the pace of change. Headlines react, rhetoric reassures, but strategic clarity is elusive.
In a global technology landscape dominated by speed, scale and spectacle, Philips is pursuing a different ambition. Not to reclaim market leadership in the traditional sense, but to redefine what leadership in medical technology means in the first place.
Social media has evolved from a platform for personal exchange into a central arena of public life, where digital footprints now serve as tools for state oversight. Governments worldwide increasingly treat posts, likes and messages as sources of intelligence. What begins as access to data can, depending on the system, remain a regulated investigative tool or transform into an instrument of control.
When Peter Wennink stepped down as CEO of ASML in April 2024, he left behind a legacy that transcended the semiconductor industry. Under his stewardship, ASML not only became Europe’s most valuable technology company but also a pivotal player in the geopolitical tug-of-war between the United States and China.
Germany’s AI ecosystem is anchored in its universities—technical institutes, research clusters and applied science centers that have produced decades of engineering excellence. Yet as AI becomes increasingly commercial, these institutions face a structural challenge: how to preserve scientific depth while accelerating translation into market-ready technologies. Universities remain strong in fundamental research, but Germany now confronts a global race in which agility, speed and capital often outweigh legacy and tradition.
